TG Therapeutics | TGTX - 债务



金融业
股票价格
USD
资产
USD 1.53B
现金及等价物
USD 442.21M
销售成本
USD 33.51M
流动资产
USD 1.09B
流动负债
USD 187.11M
债务
USD 253.71M
EBIT
USD 34.8M
EBITDA
USD 51.69M
员工
338
EPS每股收益
USD 0.12
股本和储备
USD 583.13M
销售毛利
USD 171.41M
债务利息支出
USD 7.67M
贷款资金
USD 745.14M
市值
USD 6.1B
净收入
USD 19.78M
营业费用
USD 170.12M
营业利润
USD 34.8M
普通股股本
USD 155.31M
PE价格收益
10.76
税前利润
USD 20.36M
销售收入
USD 194.8M
销售和管理费用
USD 73.14M
股票
USD 129.03M
贸易债权人
USD 148.85M
应收帐款人
USD 392.05M


债务 更改 日
AbbVie USD 67.5B 67.5B 2025-12
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Amgen USD 54.6B 17M 2025-12
Ardelyx USD 207.61M 968K 2025-09
Arrowhead Research USD 312.77M 53.52M 2025-12
Bayer EUR 36.45B 2.93B 2025-12
Biogen USD 6.56B 275.1M 2026-03
Corcept Therapeutics USD 6.11M 251K 2025-12
Curis USD 0 0 2022-06
Gilead Sciences USD 24.94B 5M 2025-12
Infinity Pharmaceuticals USD 0 0 2022-06
J&J USD 47.93B 2.14B 2025-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Novartis USD 47B 11.62B 2026-03
Novavax USD 233.31M 4.23M 2024-09
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
TG Therapeutics USD 253.71M 8.37M 2025-12
Verastem USD 66.79M 26.7M 2024-09
Vertex Pharmaceuticals USD 1.99B 44M 2026-03